3-57483370-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001366028.2(DNAH12):c.1650+6G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.674 in 1,538,730 control chromosomes in the GnomAD database, including 351,652 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001366028.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH12 | NM_001366028.2 | c.1650+6G>A | splice_region_variant, intron_variant | ENST00000495027.6 | NP_001352957.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH12 | ENST00000495027.6 | c.1650+6G>A | splice_region_variant, intron_variant | 5 | NM_001366028.2 | ENSP00000418137.2 | ||||
DNAH12 | ENST00000351747.6 | c.1650+6G>A | splice_region_variant, intron_variant | 5 | ENSP00000295937.3 | |||||
DNAH12 | ENST00000389536.8 | c.1650+6G>A | splice_region_variant, intron_variant | 5 | ENSP00000374187.4 |
Frequencies
GnomAD3 genomes AF: 0.668 AC: 101510AN: 151852Hom.: 34167 Cov.: 31
GnomAD3 exomes AF: 0.670 AC: 97747AN: 145998Hom.: 33399 AF XY: 0.677 AC XY: 52139AN XY: 76962
GnomAD4 exome AF: 0.675 AC: 936096AN: 1386760Hom.: 317477 Cov.: 42 AF XY: 0.678 AC XY: 463593AN XY: 683678
GnomAD4 genome AF: 0.668 AC: 101565AN: 151970Hom.: 34175 Cov.: 31 AF XY: 0.672 AC XY: 49884AN XY: 74262
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at